Completion of Acclaim-1 dose escalation: Recommended Phase 2 dose of quaratusugene ozeplasmid gene therapy and Osimertinib

被引：0
|
作者：
Spira, Alexander I.
Berz, David
Jotte, Robert M.
Pachipala, Krishna K.
Berger, Mark S.
机构：
来源：
MOLECULAR CANCER THERAPEUTICS | 2023年 / 22卷 / 12期
关键词：
D O I：
10.1158/1535-7163.TARG-23-A065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
A065
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Phase 1 Dose-Escalation Study of Tomotherapy Based Stereotactic Body Radiation Therapy for Primary Hepatocellular Carcinoma
    Kim, J. W.
    Lee, I. J.
    Cha, H.
    Woo, J. Y.
    Seong, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2015, 93 (03): : S221 - S221
  • [32] Multicenter, Phase 1, Dose Escalation Study of Hypofractionated Stereotactic Radiation Therapy With Bevacizumab for Recurrent Glioblastoma and Anaplastic Astrocytoma
    Clarke, Jennifer
    Neil, Elizabeth
    Terziev, Robert
    Gutin, Philip
    Barani, Igor
    Kaley, Thomas
    Lassman, Andrew B.
    Chan, Timothy A.
    Yamada, Josh
    DeAngelis, Lisa
    Ballangrud, Ase
    Young, Robert
    Panageas, Katherine S.
    Beal, Kathryn
    Omuro, Antonio
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2017, 99 (04): : 797 - 804
  • [33] Phase 1 Dose Escalation Trial Using Stereotactic Body Radiation Therapy (SBRT) for Partial Breast Irradiation (PBI)
    Rahimi, A. S.
    Spangler, A.
    Garwood, D.
    Ding, C.
    Stevenson, S.
    Rao, R.
    Leitch, M.
    Heinzerling, J. H.
    Haley, B.
    Goudreau, S.
    Seiler, S.
    Euhus, D.
    Timmerman, R. D.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S253 - S253
  • [34] A Phase 1b Dose Escalation Safety Analysis of Lenalidomide and Azacitidine Maintenance Therapy for Poor Risk AML
    Wei, Andrew H.
    Tan, Peter T.
    Walker, Patricia A.
    Avery, Sharon
    Patil, Sushrut S.
    Schwarer, Anthony P.
    Januszewicz, Elchanan H.
    Harrison, Simon J.
    Ho, Wai Khoon
    Tam, Constantine S.
    Spencer, Andrew
    BLOOD, 2011, 118 (21) : 1548 - 1549
  • [35] Stereotactic Ablative Radiation Therapy to All Lesions in Patients With Oligometastatic Cancers: A Phase 1 Dose-Escalation Trial
    Mercier, Carole
    Claessens, Michael
    MSc, Andy Buys
    Gryshkevych, Sergii
    Billiet, Charlotte
    Joye, Ines
    Van Laere, Steven
    Vermeulen, Peter
    Meijnders, Paul
    Lofman, Fredrik
    Poortmans, Philip
    Dirix, Luc
    Verellen, Dirk
    Dirix, Piet
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 109 (05): : 1195 - 1205
  • [36] Phase 1 Study of Dose Escalation in Hypofractionated Proton Beam Therapy for Non-Small Cell Lung Cancer
    Gomez, Daniel R.
    Gillin, Michael
    Liao, Zhongxing
    Wei, Caimiao
    Lin, Steven H.
    Swanick, Cameron
    Alvarado, Tina
    Komaki, Ritsuko
    Cox, James D.
    Chang, Joe Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2013, 86 (04): : 665 - 670
  • [37] A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine
    Chris Twelves
    Alan Anthoney
    Claudio I. Savulsky
    Matthew Guo
    Larisa Reyderman
    Nicola Cresti
    Vladimir Semiglazov
    Constanta Timcheva
    Ishtiaq Zubairi
    Rosemary Morrison
    Ruth Plummer
    T. R. Jeffry Evans
    British Journal of Cancer, 2019, 120 : 579 - 586
  • [38] A phase 1b/2, open-label, dose-escalation, and dose-confirmation study of eribulin mesilate in combination with capecitabine
    Twelves, Chris
    Anthoney, Alan
    Savulsky, Claudio, I
    Guo, Matthew
    Reyderman, Larisa
    Cresti, Nicola
    Semiglazov, Vladimir
    Timcheva, Constanta
    Zubairi, Ishtiaq
    Morrison, Rosemary
    Plummer, Ruth
    Evans, T. R. Jeffry
    BRITISH JOURNAL OF CANCER, 2019, 120 (06) : 579 - 586
  • [39] Gene Therapy in Neovascular Age-related Macular Degeneration: Three-Year Follow-up of a Phase 1 Randomized Dose Escalation Trial
    Constable, Ian J.
    Lai, Chooi-May
    Magno, Aaron L.
    French, Martyn A.
    Barone, Samuel B.
    Schwartz, Steven D.
    Blumenkranz, Mark S.
    Degli-Esposti, Mariapia A.
    Rakoczy, Elizabeth P.
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2017, 177 : 150 - 158
  • [40] PHASE 1/2 DOSE ESCALATION AND DOSE EXPANSION STUDY OF TRANSCON TLR7/8 AGONIST ALONE OR IN COMBINATION WITH PEMBROLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC SOLID TUMOR MALIGNANCIES: INITIAL RESULTS FROM DOSE ESCALATION
    Davar, Diwakar
    Aghmesheh, Morteza
    Algazi, Alain
    Bajor, David
    Ganju, Vinod
    Laux, Douglas
    Spira, Alexander
    Ahern, Elizabeth
    Grewal, Jaspreet
    Rand, Jamie
    Sweis, Randy
    Karlsson, Jens-Jakob
    Kriegbaum, Mette
    Wu, Yang
    Tran, Tuan-Anh
    Singel, Stina
    Gabrail, Nashat
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A795 - A795
12345